United States Army Medical Materiel Development Activity
11
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
18.2%
2 terminated/withdrawn out of 11 trials
80.0%
-6.5% vs industry average
9%
1 trials in Phase 3/4
63%
5 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Clinical Trial Assessing Non-Inferiority of Freeze Dried Plasma to Fresh Frozen Plasma in Reversing Warfarin
Role: collaborator
ADVP005; Dengue CVD 12000 - Dengue-1-Virus Live Virus Human Challenge (DENV-1-LVHC)
Role: collaborator
HIV and STIs Clinical Study in Germany
Role: collaborator
Malaria Active Epidemiology and Treatment Study
Role: collaborator
Comparison of Full-dose Flu Vaccine to Half-dose Flu Vaccine
Role: collaborator
Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever
Role: collaborator
HIV Vaccine Trial in Thai Adults
Role: collaborator
Safety and Immunogenicity Study of a Dengue Virus DNA Vaccine
Role: collaborator
Malaria Prevention Cambodia
Role: collaborator
Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines
Role: collaborator
Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection
Role: collaborator
All 11 trials loaded